Clinical Trials List
Protocol Number97-2231A
2009-08-01 - 2010-07-31
Phase I
Study ended1
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 陸清松 Division of Neurology
- Yi-Hsin Weng Division of Neurology
- Kun-Ju Lin Division of Nuclear Medicine
The Actual Total Number of Participants Enrolled
0 Study ended
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
21 participants
-
Global
0 participants
